Metraipolis › archive › dc_eb3076c99af2

ABT-737 — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/ABT-737
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-06T23:30:40.129Z
SHA-256 of the archived text
f2c1d5f3a2269a916b78d38a9dafc56b7c5997d198a8022b336547dc960d24d7
Stable URL of this page
https://metraipolis.com/documento/dc_eb3076c99af2

How to cite

ABT-737 — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/ABT-737 (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_eb3076c99af2 (Metraipolis archive dc_eb3076c99af2, sha256 f2c1d5f3a2269a916b78d38a9dafc56b7c5997d198a8022b336547dc960d24d7)
BibTeX
@misc{dceb3076c99af2,
  title = {ABT-737 — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/ABT-737},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_eb3076c99af2; sha256 f2c1d5f3a2269a916b78d38a9dafc56b7c5997d198a8022b336547dc960d24d7},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/ABT-737. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

ABT-737 is a small molecule drug that inhibits Bcl-2 and Bcl-xL, two members of the Bcl-2 family of evolutionarily-conserved proteins that share Bcl-2 Homology (BH) domains. First developed as a potential cancer chemotherapy, it was subsequently identified as a senolytic (a drug that selectively induces cell death in senescent cells). The Bcl-2 family is most notable for their regulation of apoptosis, a form of programmed cell death, at the mitochondrion; Bcl-2 and Bcl-xL are anti-apoptotic proteins. Because many cancers have mutations in these genes that allow them to survive, scientists began working to develop drugs that would inhibit this pathway in the 1990s. ABT-737 was one of the earliest of a series of drugs developed by Abbott Laboratories (now Abbvie) to target this pathway, based on their resolution of the 3D structure of Bcl-xL and studies using high-field solution nuclear magnetic resonance (NMR) that revealed how the BH domains of these proteins interacted with their targets. ABT-737 was superior to previous BCL-2 inhibitors given its higher affinity for Bcl-2, Bcl-xL and Bcl-w. In vitro studies showed that primary cells from patients with B-cell malignancies are sensitive to ABT-737. In animal models, it improved survival, caused tumor regression, and cured a high percentage of mice. In preclinical studies utilizing patient xenografts, ABT-737 showed efficacy for treating lymphoma and other blood cancers. Unfortunately, ABT-737 is not bioavailable after oral administration, leading to the development of navitoclax (ABT-263) as an orally-available derivative with similar activity on small cell lung cancer (SCLC) cell lines. Navitoclax entered clinical trials, and showed promise in haematologic cancers, but was stalled when it was found to cause thrombocytopenia (severe loss of platelets), which was discovered to be caused by the platelets' requirement for Bcl-xL for survival. Subsequently, it was reported that ABT-737 specifically induces apoptosis in senescent cells in vitro and in mouse models.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «ABT-737» — https://en.wikipedia.org/wiki/ABT-737
Wikidata Q25105040: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q25105040
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/ABT-737?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1369610020, consultata il 2026-11-06T23:26:19.505Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 486860082cfc79cc66ccfdbaa1495d2c850d2e33b04d40ccde44f409c497517a